KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22,505	21,909	41,424	8,390	56,540	16,865
Short-Term Investments	-	-	-	2,000	6,000	2,000
Trading Asset Securities	14,064	15,786	6,889	52,690	-	-
Cash & Short-Term Investments	36,569	37,695	48,313	63,080	62,540	18,865
Cash Growth	-26.72%	-21.98%	-23.41%	0.86%	231.52%	80.64%
Accounts Receivable	16,130	14,947	14,049	15,331	16,756	15,458
Other Receivables	661.11	595.39	574.37	587.96	441.83	293.24
Receivables	16,791	15,542	14,624	16,419	17,598	15,751
Inventory	21,975	18,906	18,546	17,292	16,910	19,524
Prepaid Expenses	48.49	53.73	82.9	128.49	78.92	78.77
Other Current Assets	1,386	1,436	3,819	1,163	108.56	596.17
Total Current Assets	76,770	73,634	85,385	98,083	97,236	54,815
Property, Plant & Equipment	25,954	24,010	23,534	22,130	20,149	18,824
Long-Term Investments	5,485	5,836	4,003	3,383	4,375	399.27
Other Intangible Assets	3,787	3,962	3,497	2,865	2,973	2,467
Long-Term Deferred Tax Assets	-	-	-	563.51	669.94	775.2
Long-Term Deferred Charges	922.59	958.9	907.84	-	-	-
Other Long-Term Assets	4,174	3,987	3,977	3,923	3,998	4,040
Total Assets	117,092	112,387	121,303	130,947	129,401	81,320
Accounts Payable	9,601	7,400	7,284	7,098	6,721	8,690
Accrued Expenses	1,052	909.52	699	863.27	857.23	787.16
Short-Term Debt	4,000	4,000	18,080	50,774	7,000	10,000
Current Portion of Long-Term Debt	-	-	-	2,560	2,960	3,360
Current Portion of Leases	668.43	255.64	661.11	567.64	529.03	540.45
Current Income Taxes Payable	497.54	721.31	171.1	9.13	180.54	-
Other Current Liabilities	6,233	6,034	6,405	7,663	7,250	7,276
Total Current Liabilities	22,052	19,321	33,300	69,535	25,498	30,654
Long-Term Debt	19,261	18,542	15,926	-	43,121	-
Long-Term Leases	1,120	104.14	197.12	727.27	116.67	51.82
Long-Term Deferred Tax Liabilities	427.22	581.32	1,322	-	-	-
Other Long-Term Liabilities	116.1	0	0	-0	-0	-0
Total Liabilities	45,681	40,946	52,722	71,132	71,934	34,818
Common Stock	5,453	5,453	5,453	5,453	5,453	5,453
Additional Paid-In Capital	39,169	39,169	39,169	31,175	23,407	17,556
Retained Earnings	22,381	22,411	19,694	21,750	26,019	20,056
Comprehensive Income & Other	4,408	4,408	4,265	1,436	2,588	3,437
Shareholders' Equity	71,411	71,441	68,582	59,815	57,467	46,502
Total Liabilities & Equity	117,092	112,387	121,303	130,947	129,401	81,320
Total Debt	25,048	22,902	34,864	54,629	53,727	13,952
Net Cash (Debt)	11,520	14,793	13,449	8,451	8,813	4,913
Net Cash Growth	-33.40%	10.00%	59.13%	-4.11%	79.40%	-
Net Cash Per Share	953.50	1225.02	1284.46	777.88	801.30	503.84
Filing Date Shares Outstanding	10.91	10.91	10.91	10.91	10.91	10.91
Total Common Shares Outstanding	10.91	10.91	10.91	10.91	10.91	10.91
Working Capital	54,718	54,313	52,085	28,548	71,738	24,161
Book Value Per Share	6547.44	6550.23	6288.02	5484.28	5268.98	4263.64
Tangible Book Value	67,624	67,479	65,084	56,950	54,494	44,036
Tangible Book Value Per Share	6200.25	6186.97	5967.35	5221.60	4996.41	4037.48
Land	11,097	11,097	11,097	8,067	6,933	6,543
Buildings	15,819	15,819	15,571	15,033	15,094	14,100
Machinery	14,009	13,222	12,560	11,697	11,365	10,395
Construction In Progress	2,209	2,354	952.42	2,039	998.96	945.48

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.